MATINAS BIOPHARMA HOLDINGS, INC. Comprehensive Income
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) reported Comprehensive Income of -$10.35 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-03-31
- MATINAS BIOPHARMA HOLDINGS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was -$1.91M.
- MATINAS BIOPHARMA HOLDINGS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$1.53M.
- MATINAS BIOPHARMA HOLDINGS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-06-30 was -$5.25M.
- MATINAS BIOPHARMA HOLDINGS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-03-31 was -$1.66M.
- MATINAS BIOPHARMA HOLDINGS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$10.35M.
- MATINAS BIOPHARMA HOLDINGS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$24.03M.
- MATINAS BIOPHARMA HOLDINGS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$22.34M.
- MATINAS BIOPHARMA HOLDINGS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$21.68M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | -$1.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$3.44M derived: sum of 2 quarters · filed 2026-03-31 | -$8.69M derived: sum of 3 quarters · filed 2026-03-31 | -$10.35M 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | -$1.53M 10-Q · filed 2025-11-10 | -$6.78M derived: sum of 2 quarters · filed 2025-11-10 | -$8.43M 10-Q · filed 2025-11-10 | -$16.87M derived: sum of 4 quarters · filed 2026-03-31 | ||||
| 2025-06-30 | -$5.25M 10-Q · filed 2025-08-14 | -$6.90M 10-Q · filed 2025-08-14 | -$15.33M derived: sum of 3 quarters · filed 2026-03-31 | -$19.56M derived: sum of 4 quarters · filed 2026-03-31 | ||||
| 2025-03-31 | -$1.66M 10-Q · filed 2025-05-15 | -$10.09M derived: sum of 2 quarters · filed 2026-03-31 | -$14.31M derived: sum of 3 quarters · filed 2026-03-31 | -$19.95M derived: sum of 4 quarters · filed 2026-03-31 | ||||
| 2024-12-31 | -$8.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$12.66M derived: sum of 2 quarters · filed 2026-03-31 | -$18.29M derived: sum of 3 quarters · filed 2026-03-31 | -$24.03M 10-K · filed 2026-03-31 | ||||
| 2024-09-30 | -$4.22M 10-Q · filed 2025-11-10 | -$9.86M derived: sum of 2 quarters · filed 2025-11-10 | -$15.60M 10-Q · filed 2025-11-10 | -$20.77M derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | -$5.64M 10-Q · filed 2025-08-14 | -$11.37M 10-Q · filed 2025-08-14 | -$16.55M derived: sum of 3 quarters · filed 2025-08-14 | -$22.45M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | -$5.74M 10-Q · filed 2025-05-15 | -$10.91M derived: sum of 2 quarters · filed 2025-05-15 | -$16.81M derived: sum of 3 quarters · filed 2025-05-15 | -$22.79M derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | -$5.18M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$11.08M derived: sum of 2 quarters · filed 2025-04-15 | -$17.05M derived: sum of 3 quarters · filed 2025-04-15 | -$22.34M 10-K · filed 2025-04-15 | ||||
| 2023-09-30 | -$5.90M 10-Q · filed 2024-11-13 | -$11.88M derived: sum of 2 quarters · filed 2024-11-13 | -$17.16M 10-Q · filed 2024-11-13 | -$20.69M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | -$5.98M 10-Q · filed 2024-08-14 | -$11.26M 10-Q · filed 2024-08-14 | -$14.79M derived: sum of 3 quarters · filed 2024-08-14 | -$20.43M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | -$5.28M 10-Q · filed 2024-05-09 | -$8.81M derived: sum of 2 quarters · filed 2024-05-09 | -$14.45M derived: sum of 3 quarters · filed 2024-05-09 | -$20.50M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | -$3.52M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | -$9.17M derived: sum of 2 quarters · filed 2024-03-27 | -$15.21M derived: sum of 3 quarters · filed 2024-03-27 | -$21.68M 10-K · filed 2024-03-27 | ||||
| 2022-09-30 | -$5.64M 10-Q · filed 2023-11-08 | -$5.64M 10-Q · filed 2022-11-02 | -$11.69M derived: sum of 2 quarters · filed 2023-11-08 | -$18.15M 10-Q · filed 2023-11-08 | -$18.15M 10-Q · filed 2022-11-02 | -$25.00M derived: sum of 4 quarters · filed 2023-11-08 | ||
| 2022-06-30 | -$6.05M 10-Q · filed 2023-08-09 | -$6.05M 10-Q · filed 2022-08-11 | -$12.51M 10-Q · filed 2023-08-09 | -$12.51M 10-Q · filed 2022-08-11 | -$19.35M derived: sum of 3 quarters · filed 2023-08-09 | -$26.24M derived: sum of 4 quarters · filed 2023-08-09 | ||
| 2022-03-31 | -$6.46M 10-Q · filed 2023-05-10 | -$6.46M 10-Q · filed 2022-05-12 | -$13.31M derived: sum of 2 quarters · filed 2023-05-10 | -$20.19M derived: sum of 3 quarters · filed 2023-05-10 | -$25.07M derived: sum of 4 quarters · filed 2023-05-10 | |||
| 2021-12-31 | -$6.84M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | -$13.73M derived: sum of 2 quarters · filed 2023-03-15 | -$18.61M derived: sum of 3 quarters · filed 2023-03-15 | -$23.66M 10-K · filed 2023-03-15 | -$23.66M 10-K · filed 2022-03-08 | |||
| 2021-09-30 | -$6.89M 10-Q · filed 2022-11-02 | -$11.77M derived: sum of 2 quarters · filed 2022-11-02 | -$16.81M 10-Q · filed 2022-11-02 | -$23.29M derived: sum of 4 quarters · filed 2022-11-02 | ||||
| 2021-06-30 | -$4.88M 10-Q · filed 2022-08-11 | -$9.92M 10-Q · filed 2022-08-11 | -$16.40M derived: sum of 3 quarters · filed 2022-08-11 | -$21.96M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | -$5.05M 10-Q · filed 2022-05-12 | -$11.52M derived: sum of 2 quarters · filed 2022-05-12 | -$17.09M derived: sum of 3 quarters · filed 2022-05-12 | -$22.74M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | -$6.48M derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-03-11 | -$12.04M derived: sum of 2 quarters · filed 2022-03-11 | -$17.70M derived: sum of 3 quarters · filed 2022-03-11 | -$22.22M 10-K/A · filed 2022-03-11 | ||||
| 2020-09-30 | -$5.56M 10-Q · filed 2021-11-08 | -$11.22M derived: sum of 2 quarters · filed 2021-11-08 | -$15.74M 10-Q · filed 2021-11-08 | -$21.32M derived: sum of 4 quarters · filed 2021-11-08 | ||||
| 2020-06-30 | -$5.66M 10-Q · filed 2021-08-10 | -$10.18M 10-Q · filed 2021-08-10 | -$15.75M derived: sum of 3 quarters · filed 2021-08-10 | -$20.16M derived: sum of 4 quarters · filed 2021-08-10 | ||||
| 2020-03-31 | -$4.52M 10-Q · filed 2021-05-10 | -$10.10M derived: sum of 2 quarters · filed 2021-05-10 | -$14.50M derived: sum of 3 quarters · filed 2021-05-10 | -$17.85M derived: sum of 4 quarters · filed 2021-05-10 | ||||
| 2019-12-31 | -$5.57M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | -$9.98M derived: sum of 2 quarters · filed 2021-03-29 | -$13.32M derived: sum of 3 quarters · filed 2021-03-29 | -$17.37M 10-K · filed 2021-03-29 | ||||
| 2019-09-30 | -$4.40M 10-Q · filed 2020-11-06 | -$7.75M derived: sum of 2 quarters · filed 2020-11-06 | -$11.80M 10-Q · filed 2020-11-06 | |||||
| 2019-06-30 | -$3.34M 10-Q · filed 2020-08-10 | -$7.40M 10-Q · filed 2020-08-10 | ||||||
| 2019-03-31 | -$4.05M 10-Q · filed 2020-05-11 | |||||||
| 2018-12-31 | -$14.08M 10-K · filed 2020-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |